IceCure Medical Ltd.

ICCM Nasdaq SEC CIK 1584371
Follow IceCure Medical Ltd. Weekly email: filings, results

Financials

Reported figures only · latest: Q4 2025 USD · US GAAP
EPS, diluted -

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
$0$2M$4M$6MFY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenue
FY25$3.4M
FY24$3.3M
FY23$3.2M
FY22$3.1M
FY21$4.1M
FY20$3.9M
FY19$1.6M
FY18-
MarginsShare of revenue
  • Gross margin
  • Operating margin
−600%−400%−200%0%200%FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating margin
FY2536.3%−446.7%
FY2444.1%−476.9%
FY2340.3%−482.4%
FY2246.8%−542.6%
FY2153%−235%
FY2063.2%−107.1%
FY1932.2%−294%
FY18--
Free cash flowOperating cash flow minus capital expenditure
−$20M−$15M−$10M−$5M$0FY18FY19FY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25−$14.6M
FY24−$12.6M
FY23−$13M
FY22−$15.2M
FY21−$13.1M
FY20−$3.9M
FY19−$2.1M
FY18-